Cargando…
Anaphylactic reaction to gonadotropin‐releasing hormone analogues: a pediatric case report
Gonadotropin‐releasing hormone (GnRH) analogues represent the gold standard treatment for precocious puberty. Allergic‐type reactions in children due to this type of treatment are very rare. However, caregivers should be aware of the potential GnRH analogue systemic reactions.
Autores principales: | Ricci, Franco, de Martino, Maurizio, Stagi, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028363/ https://www.ncbi.nlm.nih.gov/pubmed/29988657 http://dx.doi.org/10.1002/ccr3.1550 |
Ejemplares similares
-
A Case of Cyclic Vomiting Syndrome Responding to Gonadotropin-Releasing Hormone Analogue
por: Shin, Young Kook, et al.
Publicado: (2010) -
Early preclinical work with gonadotropin-releasing hormone analogues
por: Gordon, Keith
Publicado: (2023) -
Remdesivir: Anaphylactic reaction: case report
Publicado: (2021) -
Tozinameran: Pseudo-anaphylactic reactions : case report
Publicado: (2021) -
Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria
por: Brik, Tessa, et al.
Publicado: (2020)